A randomised single-blind placebo-controlled study to investigate the safety tolerability immunogenicity pharmacokinetics and pharmacodynamics of intravenous infusion of GSK933776 in Alheimers patient (2008–2009)

Grant type:
Glaxo Smith Kline Aust. Pty Ltd
Researchers:
  • Professor
    Royal Brisbane Clinical Unit
    Faculty of Medicine
    Affiliate Professor
    UQ Centre for Clinical Research
    Faculty of Medicine
Funded by:
GlaxoSmithKline Australia Pty Ltd